AUC 0–24 and C max of pyrazinamide showed a trend to lower exposure in diabetic versus non-diabetic TB patients, but these differences did not reach statistical significance.
← all excerpts
Effect of diabetes mellitus on TB drug concentrations in Tanzanian patients.
1
—
—